Shuangling Chen

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. pmc Human prostate cancer initiating cells isolated directly from localized cancer do not form prostaspheres in primary culture
    Shuangling Chen
    Chemical Therapeutic Program, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland 21231, USA
    Prostate 72:1478-89. 2012
  2. pmc Quantification of Mesenchymal Stem Cells (MSCs) at sites of human prostate cancer
    W Nathaniel Brennen
    Chemical Therapeutics Program, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA
    Oncotarget 4:106-17. 2013
  3. pmc Adaptive auto-regulation of androgen receptor provides a paradigm shifting rationale for bipolar androgen therapy (BAT) for castrate resistant human prostate cancer
    John T Isaacs
    The Chemical Therapeutic Program, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Prostate 72:1491-505. 2012

Collaborators

  • Jun Luo
  • Lizamma Antony
  • John T Isaacs
  • W Nathaniel Brennen
  • Samuel R Denmeade
  • Jason M D'Antonio
  • Susan P Dalrymple
  • Georges H Ndikuyeze

Detail Information

Publications3

  1. pmc Human prostate cancer initiating cells isolated directly from localized cancer do not form prostaspheres in primary culture
    Shuangling Chen
    Chemical Therapeutic Program, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland 21231, USA
    Prostate 72:1478-89. 2012
    ..Thus, there is an urgent need to develop new approaches to achieve the "routine" establishment of CIC containing lines, particularly derived from primary prostate cancers...
  2. pmc Quantification of Mesenchymal Stem Cells (MSCs) at sites of human prostate cancer
    W Nathaniel Brennen
    Chemical Therapeutics Program, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA
    Oncotarget 4:106-17. 2013
    ....
  3. pmc Adaptive auto-regulation of androgen receptor provides a paradigm shifting rationale for bipolar androgen therapy (BAT) for castrate resistant human prostate cancer
    John T Isaacs
    The Chemical Therapeutic Program, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Prostate 72:1491-505. 2012
    ..BAT therapy is effective in xenografts and based upon positive results has entered clinical testing...